Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
11,094,129
-
Share change
-
+25,549
-
Total reported value
-
$16,975,000
-
Price per share
-
$1.53
-
Number of holders
-
19
-
Value change
-
-$40,233
-
Number of buys
-
7
-
Number of sells
-
10
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q3 2015
As of 30 Sep 2015,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,094,129 shares.
The largest 10 holders included
Senvest Management, LLC, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, Opaleye Management Inc., Nine Chapters Capital Management LLC, and Benchmark Capital Advisors.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.